Showing results (351-360 of 651) with videos related to

Sort By:
Pageof 66
Clinical Kidney Journal|February 23, 2024
Dapagliflozin in chronic kidney disease: cost-effectiveness beyond the DAPA-CKD trialPhil McEwan, Jason A Davis, Peter D Gabb, et al.
Nephron. Clinical Practice|January 22, 2011
Endothelial progenitor cells in long-standing asymptomatic type 1 diabetic patients with or without diabetic nephropathyHenrik Reinhard, Peter Karl Jacobsen, Maria Lajer, et al.
Scientific Reports|July 27, 2021
Faecal biomarkers in type 1 diabetes with and without diabetic nephropathySigne Abitz Winther, Miia Maininki Mannerla, Marie Frimodt-Møller, et al.
Cardiovascular Diabetology|August 2, 2011
Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuriaHenrik Reinhard, Mads Nybo, Peter R Hansen, et al.
Cardiovascular Diabetology|February 12, 2020
Relation of cardiac adipose tissue to coronary calcification and myocardial microvascular function in type 1 and type 2 diabetesEmilie H Zobel, Regitse Højgaard Christensen, Signe A Winther, et al.
Diabetes, Obesity & Metabolism|August 13, 2021
Liraglutide reduces cardiac adipose tissue in type 2 diabetes: A secondary analysis of the LIRAFLAME randomized placebo-controlled trialIda K B Rasmussen, Emilie H Zobel, Rasmus S Ripa, et al.
Journal of Hypertension|May 1, 2024
Multiple urinary peptides are associated with hypertension: a link to molecular pathophysiologyEmmanouil Mavrogeorgis, Margarita Kondyli, Harald Mischak, et al.
Diabetes, Obesity & Metabolism|June 6, 2023
Evaluation of the effects of ezetimibe on albuminuria and kidney fat in individuals with type 2 diabetes and chronic kidney diseaseNiels Søndergaard Heinrich, Rune Ploegstra Pedersen, Mark Bitsch Vestergaard, et al.
Journal of the American Society of Nephrology : JASN|January 18, 2008
ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathyHans-Henrik Parving, Dick de Zeeuw, Mark E Cooper, et al.
Kidney Diseases (Basel, Switzerland)|June 24, 2025
Efficacy and Safety of Finerenone in Asian Patients with Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY AnalysisTakashi Wada, Stefan D Anker, Zhihong Liu, et al.
Pageof 66